Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.470
+0.010 (0.68%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Pliant Therapeutics Employees
Pliant Therapeutics had 171 employees as of December 31, 2024. The number of employees increased by 13 or 8.23% compared to the previous year.
Employees
171
Change (1Y)
13
Growth (1Y)
8.23%
Revenue / Employee
n/a
Profits / Employee
-$1,229,848
Market Cap
90.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PLRX News
- 21 days ago - Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - GlobeNewsWire
- 25 days ago - Pliant Therapeutics: An Activist On Deck - Seeking Alpha
- 6 weeks ago - Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 6 weeks ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PRNewsWire
- 6 weeks ago - Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder - Benzinga
- 2 months ago - Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis - GlobeNewsWire